- All sections
- C - Chemistry; metallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 327/32 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
Patent holdings for IPC class C07C 327/32
Total number of patents in this class: 57
10-year publication summary
8
|
4
|
4
|
4
|
1
|
2
|
10
|
3
|
8
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alnylam Pharmaceuticals, Inc. | 1128 |
18 |
The Brigham and Women's Hospital, Inc. | 2131 |
5 |
Promentis Pharmaceuticals, Inc. | 16 |
4 |
Syngenta Participations AG | 3039 |
2 |
Mitsubishi Chemical Corporation | 4430 |
2 |
XPD Holdings, LLC | 6 |
2 |
Abliva AB | 40 |
2 |
Vectivbio Comet AG | 6 |
2 |
Hoffmann-La Roche Inc. | 3252 |
1 |
Sanofi-Aventis Deutschland GmbH | 2604 |
1 |
Toshiba Corporation | 12022 |
1 |
FUJIFILM Corporation | 28467 |
1 |
Ajinomoto Co., Inc. | 2316 |
1 |
JSR Corporation | 2473 |
1 |
Arcturus Therapeutics, Inc. | 164 |
1 |
National Central University | 222 |
1 |
Nissan Chemical Industries, Ltd. | 1762 |
1 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 803 |
1 |
Takasago International Corporation | 403 |
1 |
Zhejiang Huahai Pharmaceutical Co., Ltd. | 197 |
1 |
Other owners | 8 |